Abstract | Biochemical reactions are intrinsically stochastic, leading to variation in the production of mRNAs and proteins within cells. In the scientific literature, this source of variation is typically referred to as 'noise'. The observed variability in molecular phenotypes arises from a combination of processes that amplify and attenuate noise. Our ability to quantify cell-to-cell variability in numerous biological contexts has been revolutionized by recent advances in single-cell technology, from imaging approaches through to 'omics' strategies. However, defining, accurately measuring and disentangling the stochastic and deterministic components of cell-to-cell variability is challenging. In this Review, we discuss the sources, impact and function of molecular phenotypic variability and highlight future directions to understand its role.
The intrinsic stochasticity of biochemical reactions contributes to a wide distribution of expression of a given mRNA or protein across a seemingly homogeneous population of cells 1, 2 This phenomenon, which we call 'noise' , has been widely studied in prokaryotic and eukaryotic systems, and understanding its functional role in development, health and disease is the subject of ongoing research. Classically, noise has been quantified with use of fluorescent reporter measurements of gene expression across bacterial cells and has been broadly separated into intrinsic and extrinsic noise 1, 3 (Box 1). Genetic and epigenetic features as well as translational events modulate intrinsic noise in a gene-specific manner [3] [4] [5] . Extrinsic noise arises via unobserved variation of cellular components, such as when cells reside in different cellular states (for example, cell cycle, cell-to-cell signalling and metabolism) within an otherwise homogeneous cell population [6] [7] [8] . However, it is unknown whether these sources are independent of each other and to what extent the biological process that generates extrinsic noise is stochastic or deterministic. Furthermore, cells use a variety of regulatory mechanisms to buffer such variation, leading to an attenuation in noise across the population 9 . Recent technological advances have made possible the in-depth measurement and analysis of molecular variability in cell populations. Imaging methods 10 and single-cell 'omics' techniques 11 permit the quantification of thousands of mRNA species, the genomic sequence, its epigenetic modification and selected sets of proteins per cell. Moreover, the development of multi-omics technologies opens the possibility to link cell-to-cell variation between multiple regulatory layers across individual cells 12 . When cost, throughput and content are considered, single-cell RNA sequencing (scRNA-seq) provides the best option to study variability within cell populations. This is reflected in the broad use of scRNA-seq in recent studies where cell-to-cell variability in gene expression has been used as a proxy for transcriptional noise 13, 14 . The application of high-throughput scRNA-seq to mammalian systems has allowed the role of transcriptional variability to be characterized in a variety of contexts. One well-studied system is early embryonic development, which is driven by continuous cell-fate decision events. Several recent studies have hinted at changes in transcriptional variability in pluripotent cells between developmental stages [15] [16] [17] . Such variability is not confined to development as animal immune systems display substantial intracell-type and intercell-type heterogeneity. Here, molecular phenotypic variation promotes immune cell plasticity, thus facilitating cellular responses to pathogens 18, 19 . Conversely, uncontrolled variability in cellular systems can disrupt tissue function. For example, genetic and non-genetic heterogeneity within cell populations have been implicated in cancer development 20 . Additionally, the complete eradication of tumour cells is hindered by non-genetic phenotypic variation, which may facilitate resistance to treatment 21, 22 . Similarly, transcriptional variability increases with age and has been shown to disrupt otherwise synchronized immune responses 23 . Furthermore, disruption of noise control may lead to a blurring of cell identity, as defined by specific hormone production 24 . In this Review, we begin by defining the distinction between noise and observable cell-to-cell variability in molecular measurements. Within this context, we describe sources of variability and how recently developed single-cell sequencing and imaging technologies have facilitated the genome-wide quantification of transcriptional, epigenetic and protein variability across thousands of cells. Finally, we give an overview of current challenges in experimental and computational approaches to precisely measure, validate and perturb cell-to-cell variability and highlight future directions to understand the role of variability in biological systems and human health.
Noise and molecular phenotypic variability Throughout this Review, we define noise as stochastic events at the level of transcription and translation (see Box 1) . However, the effects of such events are subtle and difficult to directly measure. We therefore draw a distinction between noise and molecular phenotypic variability, which can be directly measured with the technologies explained below. In this context, we consider the mRNA and protein abundance of individual cells as the molecular phenotype. Variability in the molecular phenotype across cells reflects a combination of stochastic noise components and regulatory mechanisms that cells use to modulate noise (see also Ecker et al. 25 ).
Multilayered sources of phenotypic variability
In prokaryotic and eukaryotic cells, transcription occurs in 'bursts' , where RNAs are produced during an interval of active transcription followed by periods of transcriptional inactivity [26] [27] [28] [29] . In the simple 'random telegraph' model of transcriptional bursting 30, 31 , the promoter switches between an on state -in which, with a certain probability, transcripts are produced -and an off state 32 . This system is characterized by the 'burst frequency' , which captures the frequency of the on switch scaled by RNA lifetime, and the 'burst size' , which measures the number of transcripts that are produced per burst. Transcriptional bursting is often profiled with use of single-molecule fluorescence in situ hybridization (smFISH) 33, 34 or the MS2 stem loop system 26,27 . Additionally, a recent study used allele-specific expression quantified by scRNA-seq to measure burst kinetics in mouse fibroblasts 35 . Recently, it was proposed that specifically the burst frequency and the rate of burst initiation are controlled by enhancer-promoter interactions 36, 37 . Furthermore, changes in burst frequency control the upregulation or downregulation of genes associated with Dictyostelium discoideum differentiation. This in turn leads to a reduction in variability for upregulated genes 38 . However, in D. discoideum, transcriptional bursting is regulated primarily by the promoter sequence and only weakly by long-range chromatin interactions 39 . In addition to burst control during development, enhancer-promoter interactions also modulate transcriptional bursts following signalling via the oestrogen receptor. Here, variability in TFF1 expression arises due to long periods of repressed transcription 40 . Although it was initially believed that bursts occur in a stochastic fashion, the recent findings of enhancer-controlled bursts indicate that transcriptional variability can be precisely regulated during development or cellular stimulation.
Transcriptional bursting leads to large variability in transcript levels, which can propagate to form variability in protein abundance. Given its importance, understanding what might regulate molecular phenotypic variability is a critical challenge. Consequently, we focus below on discussing genomic features that have been linked to modulating both noise and molecular phenotypic variability during transcription and translation (for an overview, see Fig. 1 ).
DNA level. One of the key regulatory steps before RNA synthesis is the binding of transcription factors to specific DNA sequences within the regulatory region (promoter) of a gene, which triggers the controlled production of primary RNA transcripts from this gene 41 . Consequently, it is unsurprising that several studies have linked promoter architecture and sequence to the level of transcriptional variability. For example, genes with TATA-box-containing promoters show high levels of variability in transcript abundance 14 . Moreover, this set of genes shows an increased interspecies variability 42 and higher spontaneous mutational variation 43 . The TATA box is therefore one genomic feature that can differentiate between genes with variable and stable expression. TATA box motifs are enriched among genes that need to respond rapidly to environmental stresses, suggesting a role for transcriptional variability in adjusting to changing environmental conditions 44 
.
It has also been shown that transcriptional variability increases with the number of transcription factor binding sites 45 and decreases with the number of transcriptional start sites (TSSs) 14 . The observation that TATA-box-containing promoters also contain more 
MS2 stem loop system
Spatial detection of individual RNA molecules by binding of the gFP-tagged MS2 bacteriophage protein to MS2 RNA-binding sequences inserted in the non-coding regions of target RNA molecules.
Box 1 | Defining and measuring noise
Noise is defined as the stochastic effects in biochemical processes such as transcription and translation that contribute to cell-to-cell phenotypic differences. Classically, noise was separated into intrinsic and extrinsic noise 1 . In this definition, intrinsic noise originates from stochastic biochemical effects that directly influence mRNA and protein expression in a gene-specific manner by, for example, transcription factor binding dynamics 141 . Extrinsic noise, on the other hand, introduces covariation across multiple genes (also in a pathway-specific manner 142 ), and may arise due to fluctuations in cell-specific factors such as stress response, mitochondrial maintenance, amino acid synthesis 143 or cell cycle 6 . However, we argue that this binary classification is too simplistic, as the relative contributions of stochastic and deterministic factors to extrinsic noise are not well understood. Here, we use the term 'noise' to describe truly stochastic effects in biochemical reactions (see the figure below).
Time-resolved measurements of individual genes across cells were initially used to study noise in unicellular organisms 1, 26, 27 . More recently, single-cell technologies have been used to study noise 13, 14 and other sources of cell-to-cell phenotypic variability. However, in reality we are not able to delineate between stochastic and deterministic influences on variability, leading to a composite measurement that we define as 'molecular phenotypic variability' (also referred to as 'non-genetic heterogeneity' 144 ), which can be directly measured with the technologies described in the main text. 42 and are depleted of histone marks associated with active transcription 46 highlights that multiple correlated genomic features are associated with modulation of the effect of noise, thus highlighting challenges in disentangling the underlying sources of transcriptional variability.
Recently, the presence of Cpg islands (CGIs) in gene bodies, the TSS and promoter regions was linked to a reduction in transcriptional variability 14 . These findings introduce CGIs as DNA features that can regulate molecular phenotypic variability across cells. Morgan and Marioni 13 further distinguished between genes controlled by promoters associated with short and long CGIs. Similarly to the presence of TATA box motifs, the length of CGIs in promoter regions controls how variably a gene is expressed: genes associated with short CGIs tend to be more variably expressed, allowing an early response to stimulation, exemplified by observations in mouse bone-marrow-derived dendritic cells and human breast cancer cells 13 . Epigenetic level. Besides DNA sequence, gene transcription is also modulated by epigenetic factors that control the chromatin state. Chromatin describes the packaged state of DNA; its central elements are nucleosomes, which are combinations of eight of the four histones (H3, H4, H2A, H2B), around which 147 bases of DNA twist. At the DNA level, epigenetic modifications include the methylation of CpG dinucleotides and represent distinct regulatory elements. Methylation of CpG sites around promoters is linked to gene silencing, whereas DNA methylation in gene bodies is associated with transcription 47 .
Modifications of histones can induce the activation or repression of chromatin and therefore modulate gene expression 48 . In a comprehensive study of the link between histone modifications and expression variability, Faure et al.
14 detected several histone modifications in promoters and in gene bodies that were associated with either increased or decreased variation in gene expression. They found that bivalent promoters, which carry the repressive H3K27me3 mark deposited by Polycomb repressive complex 2, and the activationassociated H3K4me3 mark, display high transcriptional variability 14 . One potential explanation for this observation was provided by Kar et al. 49 , who combined information on Polycomb repressive complex histone modifications with RNA polymerase II (RNAPII) activity marks to infer that switching between the repressed and active states introduces gene expression variability across a population of cells.
Besides the modification of histones, the positioning of nucleosomes can also control the magnitude of transcriptional variability. Tirosh and Barkai 50 showed that genes with promoters that have high nucleosome occupancy proximal to the TSS tend to display relatively more plastic expression levels across perturbations such as environmental stress, mutations and developmental transitions.
A key limitation in using these epigenetic modifications to construct a phenotypic molecular variability code is that most measurements are made using technologies that average signals across millions of cells. For example, the increased variation in expression caused by high nucleosome occupancy close to the TSS could also be driven by cell-to-cell variations in nucleosome occupancy. Indeed, limited single-cell profiling of nucleosome occupancy around the Saccharomyces cerevisiae PHO5 promoter demonstrated variability in nucleosome position on stress induction. Additionally in the non-stressed environment, a small fraction of cells still exhibit nucleosome-free regions at the promoter, which can explain the variable expression of PHO5 (ReF. 51 ).
These findings contribute to a general theme: apparently repressed promoters can be associated with variable levels of expression across a cell population 14 .
Transcriptional level. Transcription is initiated by transcription factors binding to specific regulatory DNA sequences, followed by recruitment of RNAPII and RNA synthesis (Fig. 1) . As discussed earlier, promoter architecture, namely the location and accessibility of transcription factor binding sites and RNAPII binding sites, controls mean expression and shapes noise. The assembly of RNAPII complexes has been linked to modulation of transcriptional variability. An early study identified the connection between paused RNAPII and synchronous expression of target genes in Drosophila melanogaster: genes without preloaded RNAPII showed more stochastic activation patterns 5 . This finding was later confirmed with use of scRNA-seq data for genes transcribed across the full range of expression levels. However, the genes with preloaded RNAPII also have a higher CpG content and are depleted of TATA box elements 52 . Once again, the correlation between genomic factors and their individual associations with variation creates a challenge to disentangle the underlying sources of molecular phenotypic variability.
Post-transcriptional and translational levels. After synthesis, pre-mRNAs are polyadenylated and spliced to form mature mRNAs that relocate from the nucleus to the cytoplasm, where translation occurs. On the post-transcriptional and translational levels, nuclear export, degradation and the efficiency of translation have been shown to influence cell-to-cell variation in mRNA and protein abundance.
Battich et al. 53 proposed that the active export of mRNAs into the cytoplasm functions as a buffering mechanism to reduce cell-to-cell variation in transcript abundance. Concordant with a role for nuclear export as a mechanism for modulating variation, Bahar Halpern et al. 54 demonstrated, for two genes expressed in the liver, lower variation of transcripts in the cytoplasm compared with transcripts localized to the nucleus. They proposed that this could be a regulatory mechanism that is active across a range of metabolic tissues 54 . Conversely, Hansen et al. 55 recently proposed that nuclear export amplifies transcript variability in the cytoplasm compared with the nucleus. Their study used the theoretically correct assumption that the Fano factor (variance divided by mean expression) does not scale with mean expression. However, in practice and as discussed by Grün et al. 56 when using scRNA-seq data or Sanchez and Golding 29 when using smFISH data, this assumption does not hold when technical or biological effects influence the global variation in transcript counts (see the section Computational quantification of variability).
Therefore, the comparison of the Fano factor might still be confounded by changes in mean transcript abundance. Another potential explanation for this discor dance is that Battich et al. 53 profiled HeLa cells that were stimulated with epidermal growth factor (EGF), where the buffering effect of nuclear export might not be comparable to the steady-state system used by Hansen et al. 55 .
Other mechanisms to control cytoplasmic variations in transcript abundance include accelerated mRNA degradation driven by microRNAs (miRNAs). This process has been shown to preferentially reduce variation in transcript abundance for lowly expressed genes in mouse embryonic stem cells, possibly to maintain cellular identity 57 . Ribosomes binding to mRNA and subsequent translation to a peptide sequence are biochemical processes and so may also be subjected to stochastic fluctuations (that is, noise). Therefore, it is difficult to disentangle variation in translation from noise that propagates from all previous layers of the central dogma of molecular biology; that is, transcription, splicing and mRNA export. To specifically study the contribution of noise at the level of translation, Ozbudak et al. 3 mutated the ribosomal binding site of a GFP reporter gene transfected into Bacillus subtilis. This altered ribosomal binding site had an impact on translational efficiency and fluctuations in protein abundance 3 , highlighting that translational noise also influences molecular phenotypic variation.
Molecular phenotypic variability at the cell population level. As discussed already, molecular phenotypic variability of mRNA, protein or other biological molecules results from a combination of stochastic and deterministic influences (Fig. 2) . Classically, time-resolved singlegene measurements have been used to study the effect of noise, and perturbation experiments have been used to infer the influences of specific regulatory layers. The recent advent and adoption of high-throughput singlecell technologies, which we discuss in the following sections, provides us with the ability to assay molecular phenotypic variability genome-wide. Therefore, using these modalities, we can measure variability at different scales, from a single gene to large, cell-type-specific and cell-state-specific gene regulatory networks in a single experiment (Box 2; Fig. 2 ).
Measuring variability
In the past ten years, the scale of single-cell assays has increased from measuring a few genomic, epigenetic, transcriptomic or proteomic features to measuring hundreds of thousands. These technologies can be used to measure molecular phenotypic variability, as well as to gain an understanding of the regulatory features that modulate it. The ability to study noise using technologies that destroy the cell is formulated on the basis that a cross-sectional measurement over a population of cells is representative of the time-resolved noise profile of any given cell 3 . The in-depth technical details of single-cell assays are explained elsewhere [58] [59] [60] , and here we highlight how current state-of-the-art technologies have been used to understand phenotypic variability (also discussed by Patange et al. 61 ).
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Single-cell whole-genome sequencing. Single-cell whole-genome sequencing (scDNA-seq) has been used to identify copy number variants (CNVs) and singlenucleotide variants (SNVs) between single cells 62 . Recently, Vitak et al. 63 introduced single-cell combinatorial indexed sequencing (SCI-seq), which allows the generation of thousands of single-cell genomes for sequencing. In this way, CNVs of more than 15,000 cells can be assessed. Consequently, whereas bulk measures have been used to link mutations to changes in transcriptional variations 64, 65 , scDNA-seq, with high read depth, can potentially be used to ask whether a heterogeneous mutational pattern (somatic mutations) drives observed fluctuations in phenotypic variability.
Single-cell epigenomic methods. These techniques capture the chromatin state, histone modifications and/or DNA methylation of individual cells and allow quantification of epigenetic variability across a population of cells 60 . Similarly to scRNA-seq and scDNA-seq, the scale of single-cell epigenomic technologies has recently been increased by the application of combinatorial indexing approaches 66, 67 . This will potentially allow variable patterns of histone modifications or nucleosome positioning to be linked with gene expression variability 51 .
Single-cell RNA sequencing. This typically quantifies poly(A)-tagged mRNA abundance in individual cells. The throughput of scRNA-seq has increased from tens or hundreds of cells to thousands and hundreds of thousands of cells, largely driven by the application of microfluidic approaches 68, 69 and combinatorial index sequencing approaches 70, 71 . The cost-efficient and genome-wide nature of scRNA-seq makes it the ideal method to study genome-wide variability in molecular phenotypes. Thus, it is ideally suited to linking genomic features to phenotype variability 14 , study changes in expression variability during development 15 and investigate responses to perturbations (such as ageing 23, 24 ).
Single-cell proteomics approaches. These methods have been developed to quantify a selected set of proteins in individual cells. High-throughput approaches to measure protein abundance from tens of thousands of cells include fluorescence-activated cell sorting (FACS) and cytometry by time of flight (CyTOF). FACS is restricted by the use of a limited set of antibodies with conjugated fluorophores that emit light in different spectral regions, whereas CyTOF allows a larger number of proteins to be quantified with use of antibodies that are labelled with transition element isotopes 72 . More recently, conjugation of antibodies with oligonucleotides has allowed protein quantification for a number of targets by next-generation sequencing 73 . Although these approaches are restricted to a relatively small set of proteins, a larger number of cells can be profiled than by scRNA-seq. Additionally, these approaches are able to capture post-translational modifications indicative of intracellular signalling that are unobserved when variability in mRNA abundance is profiled.
Spatial approaches. These techniques allow the quantification of molecular variation in biological systems by recording the position of RNAs or proteins in individual cells. The methods include the expression of fluorescent proteins controlled by promoters of interest (reporter assays) or immunocytochemistry, smFISH 33, 53, 74 and the MS2 stem loop system 26, 27 . Historically, these approaches have been able to assay only a handful of transcripts or proteins. However, the recent advent of multiplexed FISH, such as multiplex error-robust FISH (MERFISH) 
Box 2 | Structured versus unstructured variability
Molecular phenotypic variability can be observed as variation at the single-gene level or as covariation in expression between multiple genes. Whereas the lack of covariation (unstructured variability) hints at stochastic contributions to molecular phenotypic variability, covariation between genes (structured variability) indicates regulation of, for example, signalling pathways.
Extensive covariation between genes is indicative of the presence of distinct cell types, which can be accounted for by computational clustering (see Kiselev et al.
132
) or experimental cell-type selection (for example, via fluorescence-activated cell sorting (FACS)). Subtler covariation may arise due to other deterministic biological processes, such as fluctuations in metabolic states 8 , cell cycle stage 6, 89, 145 , cell volume [146] [147] [148] and cellular signalling 7, 21 . In the case of the cell cycle, computational approaches can be used to assign a cell to a distinct phase of the cell cycle, and this effect can be regressed out in subsequent analyses 133 . Experimentally, the volume or cell cycle stage of cells can be identified by profiling of marker gene expression and DNA content. Therefore, either cells can be sorted or overall protein levels can be normalized on the basis of these features 149, 150 . In this Review, we focus on unstructured variability; consequently, structured variability is a confounding factor that can be removed by either computational or experimental approaches.
www.nature.com/nrg and sequential FISH (seqFISH) -which both use combinatorial hybridization and sequential rounds of smFISH combined with super-resolution microscopynow allows the detection of hundreds of mRNA species per cell 10, 75 . The development of imaging mass cytometry 76 and highly multiplexed protein imaging has allowed spatially resolved measurement of around 40 proteins across thousands of cells 77 . Spatially resolved methods connect variability to location, thus allowing the inference and prediction of cell states 53 that would otherwise appear to be random.
Single-cell multi-omics approaches. These methods combine some of the previously described techniques to measure transcriptomic, genomic, epigenomic and proteomic ('multi-omic') features of single cells in parallel 12 . DNA and RNA sequencing (DR-seq) and singlecell genome and transcriptome sequencing (G&T-seq) perform combinatorial genome and transcriptome sequencing from the same cell 78, 79 . Single-cell methylation and transcription sequencing (scM&T-seq) was initially developed to quantify the methylome and transcriptome from single cells 80 and has been extended to capture accessible chromatin regions 81 . In recent years, different protocols have been developed to capture a selected set of proteins and mRNAs within individual cells 82, 83 . These approaches can now be used to understand how genomic features control molecular variability and how it propagates from one molecular level to another.
Computational quantification of variability
The technologies described so far generate single-cell readouts of mRNA or protein abundance. However, the quantification of molecular variability presents particular analytical challenges. Commonly, variability is quantified by one of a number of different point estimates. For example, the variance, σ 2 , calculated either across all cells or across all cells in which a gene's expression is detected 18 , captures variability in RNA or protein abundance. Assuming an underlying Poisson generative process for mRNA and protein production, the variance scales linearly with mean expression (µ) 84 (Fig. 3) . A more widely used method for measuring variable RNA 53, 85 or protein expression 86 is the (squared) coefficient of variation (CV 2 ; σ 2 /µ 2 ). However, the CV 2 decreases as a function of mean expression, which is expected from an overdispersed Poisson generative process, leading to the observation that lowly expressed genes show higher levels of variability than highly expressed genes 85, 86 ( Fig. 3) . To theoretically avoid this mean-variability dependence, numerous studies have quantified variability using the ratio of the variance to the mean (σ 2 /µ), called the Fano factor 3, 55, 87 . This statistic assumes that the overdispersion is equal across the entire range of mean expression values. However, in practice and as discussed by Grün et al. 56 and Sanchez and Golding
29
, this assumption is violated in single-cell measurements when technical or biological constraints influence the global cell-to-cell differences in transcript abundance, leading to a lower limit of variability 29, 56, 88 (Fig. 3) . Consequently, to compare variability measures for a given gene across different biological conditions, where the mean expression of a gene changes, regression approaches have been used to correct for the mean-variability relationship 89, 90 . Alternatively, several mechanistic-based approaches have been proposed to infer the specific kinetics of transcription from scRNA-seq. For instance, Kim 92 modelled expression counts from scRNA-seq data using a Bayesian framework where statistical uncertainty in parameter estimates was propagated into downstream analyses. Here, biological variability (after technical noise had been accounted for) was modelled directly 92 . Similarly to the CV 2 (ReF.
85
), this overdispersion measure decreases with increasing mean expression 92 , which has to be corrected for when testing changes in expression variability between cell populations 93 or when comparing variability measures across sets of genes. In sum, all measures of molecular phenotypic variability are influenced by a variety of potentially confounding factors, including a gene's mean expression, and care must be taken to account for these when drawing inferences about the role of biological variability.
The role of molecular phenotypic variability All cellular systems display phenotypic variability and use strategies to make use of or cope with this variation. Early research focused on studying variability in viral [94] [95] [96] , prokaryotic 1,3 and unicellular eukaryotic 97, 98 systems (for extensive summaries of these systems, see Balázsi et al. 99 and Raj and van Oudenaarden 100 ). For example, biological noise was originally thought to trigger the decision between latency and replication in the λ phage. Infected cells reside in either a lysogenic state, where the genetic material of the virus is transmitted to daughter cells without inducing cell death, or a lytic state, where the virus destroys the host cell 101 . Arkin et al. 94 modelled the lysis-lysogeny switch on the basis of stochastic chemical kinetics and expression dynamics. An alternative explanation by St-Pierre and Endy 96 described a more deterministic model, where the hetero geneity in decision events depended on the hetero geneity in cellular volume. This conflict between stochastic and deterministic mechanisms was recently resolved by Zeng et al. 95 , who proposed
Technical noise
Variation in measured components (for example, mRNA or proteins) that arises during data acquisition.
that the lysis-lysogeny switch depends not on a single noise-driven decision but on a single unanimous, noise-free vote across all phages per cell. Building on this notion of communication, in unicellular organisms, noise contri butes to 'bet hedging' , a survival strategy where a sub optimal fitness landscape is tolerated across a population of cells so as to facilitate an effective response to environmental changes. For example, B. subtilis commits to either sporulation or competence on starvation or DNA damage 102 . The probabilistic and transient activation of competence in a subpopulation of B. subtilis cells is modulated by fluctuations in the competence regulators ComK and ComS. As with the λ phage phenomenon described above, fluctuations of these regulators have both stochastic and deterministic sources. On one hand, a system of feedback loops has been proposed to control the number of cells that commit to competence while other cells irreversibly sporulate 103 . On the other hand, noise in transferring phosphoryl groups across a cascade of regulators maintains a constant probability of cells committing to sporulation 104 . Although the role of molecular phenotypic variability in unicellular systems has been extensively profiled, its impact and function in multicellular systems are largely unclear. Here we highlight recent studies using highthroughput omics techniques to characterize how higher eukaryotic systems exploit and buffer variability. ; right plots). Whereas genes in the technical samples approximately follow a Poisson trend (black points), biological cell-to-cell variability induces overdispersion in the singlecell samples (red points). When comparing measures of variability between conditions or between genes, it is crucial to correct for the mean-variability trend as observed in scRNA-seq data. Furthermore, different normalization strategies can alter the magnitude of the discrepancy between biological and technical variation. Specifically, differences in sequencing depth between cells are confounded with cell volume and size, a major contributor to molecular phenotypic variability. Therefore, common normalization strategies that remove cell-to-cell differences in sequencing depth on the basis of endogeneous genes also remove the influence of cell volume on variability; normalization methods that use external spike-in molecules retain cell volume differences. Data from ReF.
.

Sporulation
A process during which the cell's vegetative growth ends, leading to the formation of endospores that survive the altered environment.
Competence
Competent bacteria have the ability to take up DNA from the environment.
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A role for variability in multicellular organisms?
Similarly to bet-hedging strategies in unicellular organisms, noise can facilitate the switch between cell states and the probabilistic induction of differentiation 105, 106 . Cell-to-cell variability in expression increases throughout D. discoideum development 38 and as haematopoietic progenitor cells differentiate 107, 108 . Once cells are committed to a fate, variability collapses at the population level as these cells become terminally differentiated 107, 108 . However, and as we further discuss below, it is not clear if these observed changes in variability drive differentiation and, furthermore, how transcriptional variability progresses through to the protein level. For example, Baser et al. 109 recently highlighted that in mouse neurogenesis the translation of stem-cell identity factors is repressed by decreased mTOR activity on cell cycle exit. This finding exemplifies a post-transcriptional layer of regulation, which can induce differentiation independently of transcriptional variability -it is important to bear this in mind when considering the role of mRNA expression variability in determining cell fate.
One study that has linked gene expression noise with cell fate proposed that variability in expression contributes to early (pregastrulation) embryonic development 110 . As early as the four-cell-stage mouse embryo, targets of the master pluripotency factors OCT4 and SOX2 are heterogeneously expressed (Fig. 4a) . This is caused by heterogeneous methylation patterns of histone H3 Arg26 (H3R26) induced by CARM1, which in turn facilitates the binding of OCT4 and SOX2, biasing cells towards a pluripotent fate, and formation of the inner cell mass. Conversely, cells with unmethylated H3R26 are biased towards the extraembryonic trophoectoderm 15 . At embryonic day (E)3.5, cells of the inner cell mass continue to display variable gene expression (Fig. 4a) . Fibroblast growth factor 4 (FGF4)-driven signal reinforcement controls this heterogeneity, forming a spatial salt-and-pepper-like distribution of primitive endoderm and epiblast cells. By E4.5, the establishment of gene regulatory networks facilitates the positional segregation of the epiblast and primitive endoderm lineage 17 (Fig. 4a) .
In line with these observations, scRNA-seq reveals high levels of transcriptional variability in the inner cell mass at E3.5 compared with cells of the E4.5 epiblast 16 . However, transcriptional variability is not the only explanation for cell-fate commitment during early embryonic development 111 . In the transition from an 8-cell embryo to a 16-cell embryo, cell polarity, position and orientation during cell division cause differences between cells (symmetry breaking) 111 . Maître et al. 112 proposed that 
Symmetry breaking
The emergence of asymmetry regarding the distribution of factors influencing developmental potency.
NATuRE REvIEWS | GeneTicS cells may self-organize within the embryo due to differences in contractility, leading to the internalization of the more contractile cells at the 16-cell stage 112 . These alternative explanations for symmetry breaking and cell-fate decision-making beg the question of whether variability plays a role in these processes at all: expression variability may arise due to an inability to pinpoint the true decision event as cells have already begun to diverge, giving the impression that variability precedes fate choice. Therefore, variability may be a consequence rather than a cause of cell-fate decision-making.
Although controversy over the role of variability in cell-fate decision-making is apparent, it is much clearer that animal systems utilize variability to allow robust population responses to environmental changes. Fast and flexible immune responses are observed within cell populations that are highly plastic and react to a broad spectrum of stimuli. It has been proposed that stochastic cytokine expression leads to phenotypic variability in T helper (T H ) cell subtypes, increasing their ability to respond to immune stimuli 113 . For example, fluctuating expression of the lineage-defining cytokines interferon-γ (for T H 1 cell fate) and IL-4 (for T H 2 cell fate) in small populations of CD4
+ T H cells facilitates the rapid commitment towards either a T H 1 or a T H 2 cell fate 114, 115 . These observations are concordant with the notion that variability in an external signal, such as a cytokine, dictates the lineage commitment, rather than the stochastic expression of transcription factors 116 .
In line with these ideas, Hagai et al. 117 showed that variability in expression of cytokines within immune cell populations corresponds to immune response divergence between species. By contrast, the upstream regulators (such as transcription factors) tend to show lower variability and higher conservation in expression between species. Furthermore, Shalek et al. 18 showed that on lipopolysaccharide stimulation, a small subset of dendritic cells that express interferon-β become activated much earlier than the rest of the cell population. These early responders support the activation of lateresponding cells via paracrine and autocrine signalling (Fig. 4b) . Similar phenomena have been observed with IL-2 and nuclear factor-κB (NF-κB) signalling 118, 119 . For example, IL-2 demonstrates a digital (on/off) expression pattern in T H cells following immunization, where the number of IL-2 expressing cells is proportional to the signal strength 118 . This allows an organism to generate an immune response that is directly proportional to the magnitude of the external challenge.
Regulating variation in cellular systems. While cellfate decision-making and immune plasticity are linked to increased molecular phenotypic variability, cells have evolved numerous mechanisms to regulate and attenuate its impact in other settings. For example, increases in expression variability during zebrafish development can be counteracted by temporal averaging across noisy transcription events to achieve coordinated tissue responses 120 . Furthermore, at the whole-organism level, redundancy in the Caenorhabditis elegans intestinal gene regulatory network has been proposed to buffer expression variability in the downstream master regulator elt-2. When highly connected regulators of this network have been removed, phenotypic variation in intestinal differentiation arises from the bimodal expression of elt-2 (ReF.
28 ). The cooperation of positive-feedback and negative-feedback loops in these highly connected regulatory networks ensures robust expression of key developmental genes 121 . Recently, Hansen et al. 87 highlighted a system in which transcript variability is enhanced before and attenuated after fate commitment: transcriptional variability in HIV-1 is amplified by positive feedback and facilitates cell-fate commitment; subsequently, cell fate is stabilized by autodepletion of precursor RNAs, reducing transcript variability in a negative-feedback fashion 87 . These findings indicate that low-and high-variability regimes, with specific functions, can be specifically controlled in single cells.
In sum, biological systems use mechanisms to exploit and control molecular variability, which may be influenced by noise, to create a properly functioning ensemble of cells that respond to environmental signals. Loss of these control mechanisms leads to greater instability and an increase in molecular variability, with potentially detrimental consequences.
Losing control: destabilizing biological systems. As described earlier, biological noise needs to be controlled to ensure consistent tissue-wide responses. This also applies to the immune system: even though immune cells display highly variable molecular phenotypes, once they are activated, transcriptional responses are synchronized. Perturbations of this system, which have been observed during ageing, destabilize this synchronization and increase molecular variability 23, 122 . Increased variability in the expression of immune response genes, identified by genome-wide transcriptional profiling of single cells, has been proposed to destabilize the immune activation programme in CD4 + T cells
23
. Similarly, transcriptional variability increases with age in the human pancreas and is correlated with an increased stress signature and atypical hormone expression 24 . Although these studies have demonstrated a relationship between variability and ageing, they are limited in the scope of the cell types and tissues profiled. More recently, the connection between age and molecular variability has been expanded to encompass additional peripheral immune cell types and ageing lung tissue 123, 124 . Increased molecular phenotypic variability can therefore be regarded as a biomarker for ageing and a quantitative trait, which can be compared across individuals 125 . Onset and progression of cancer are also correlated with a loss of control over phenotypic variability. Gene mutations induce transitions from healthy cells towards a cancerous state 20 . Cancer cells then occupy stable transcriptional states that are inaccessible under healthy conditions 126 . Although cancer is characterized by genetic heterogeneity, non-genetic heterogeneity facilitates the accessibility and phenotypic adaptation to alternative cellular states 127 ( Fig. 4c) . Epigenetic dysregulation and increased epigenetic variability further allow the emergence and reinforcement of non-genetic heterogeneity in tumours 22 . This is supported by evidence of increased genome-wide DNA methylation
Paracrine and autocrine signalling
Autocrine hormone signalling affects the hormone-producing cell, whereas paracrine hormone signalling affects nearby cells.
Autodepletion
Depletion of precursor RNAs by their protein product.
www.nature.com/nrg heterogeneity in chronic lymphocytic leukaemia, which increases cancer cell plasticity 128 . Increased non-genetic heterogeneity at the epigenetic or transcriptional level, induced by either a spontaneous or an instructed loss of noise control, can therefore have a detrimental effect on healthy tissue function.
Another important consequence of phenotypic heterogeneity in cancer cells relates to the fractional killing of cell populations on drug treatment 129 (Fig. 4c) . Variability in the expression of proteins mediating apoptosis leads to the survival of small fractions of cells after treatment 21 , which could consequently repopulate the tumour. Similarly, the stochastic acquisition of DNA damage on cisplatin exposure introduces heterogeneity in the upregulation of p53. Slow upregulation leads to cell cycle arrest and inhibits apoptosis, with only rapid upregulation leading to cell death 130 . In patient-derived melanoma cells, sporadic expression of resistance markers forms a rare cell population that grows into resistant colonies after vemurafenib treatment. Whereas preresistant cells do not display distinct epigenetic marks and are therefore close to the non-resistant ground state, treatment induces large epigenetic reprogramming, forming stable resistant cancer colonies 22 . To surmount this problem, combinatorial therapies have been proposed to reduce variability and fractional killing in cancer cell populations 130, 131 . These studies highlight the observation that cellular systems control the effect of variability and that once this control is lost, increased variability can lead to destabilized cell responses.
Challenges
While technological and computational advances have facilitated the quantification of mRNA and protein variability across a range of cell types and tissues, major challenges remain regarding robust measurement, statistical analysis and experimental validation.
Computational and experimental concerns. Fundamentally, a Poisson process describes the underlying generative process of transcription. However, transcriptional bursting introduces additional variation in mRNA levels that is greater than expected by a Poisson process; such additional variation is referred to as overdispersion. Sequencing count data generated by scRNA-seq for studying variability are usually modelled with use of a negative binomial distribution, which incorporates this overdispersion. The natural measure of variability in this setting is either the CV 2 or the Fano factor, which both scale with the mean expression level. This relationship must be accounted for to decouple any confounding effects between mean expression and variability. Previously, this was achieved by either parametric 13, 85 or non-parametric approaches 14, 93 . Although smFISH is considered a gold standard for the quantification of molecular variability, its limited throughput does not allow an in-depth understanding of the mean-variability relationship.
Additionally, the ability to study molecular variability relies on obtaining a 'homogeneous' population of cells. However, challenges remain in defining such a population, due to insufficient resolution of subtle structured heterogeneity. Potential solutions include sensitive and robust clustering algorithms (see Kiselev et al. 132 ), as well as methods to estimate correlated sources of variability in an unbiased manner 133 . As well as the issues noted above, scRNA-seq is prone to high technical noise due to the low amount of biological input material: typically, only 10-20% of all transcripts are captured in a given cell. Furthermore, amplification biases exponentially enhance noise introduced by differences in capture efficiency. Initially, RNA spike-ins were used to decompose the overall variability into biological and technical components 85, 92 . More recently, these biases have been minimized by the introduction of unique molecular identifiers (UMIs) that allow the direct quantification of transcript abundance 134 . However, newly developed, high-throughput scRNA-seq approaches come at the price of reduced sequencing depth and the inability to quantify technical noise via RNA spike-ins. Additionally, economic constraints have meant that many scRNA-seq studies have not used biological replicates. Recently, new approaches have been developed that can potentially overcome this problem by allowing multiplexing of samples 135 . Experimental designs for single-cell studies with replication are needed to correctly estimate the technical contributions to variability where spike-ins are not available 93 .
Experimental perturbations to study the role of variability. One of the main experimental challenges when attempting to validate the hypothesized role of variability is resolving whether or not it is a cause or a consequence of the system being studied. To address these issues, one needs to perturb the molecular source, the magnitude of variability, and the consequences of variability.
Classically, unicellular systems have been used to study the sources of transcriptional variability. In these systems, genetic alterations allowed the direct modulation of transcriptional and translational variability 2, 3, 65 . Specifically, changing promoter architecture can strongly alter expression variability 45, 136 . By contrast, large-scale targeted in vivo editing in multicellular organisms has only recently become achievable due to the development of CRISPR-Cas9 approaches 137 . Furthermore, multiple correlated regulatory factors influence transcriptional variability, making it challenging to specifically dissect the influence of individual factors. To circumvent this challenge, direct manipulation of molecular variability by orthogonal means can reveal the role of variability without altering the source. For instance, modulation of miRNA-dependent mRNA degradation can be used to reduce variability in mRNA levels for specific target genes, as proposed by Schmiedel et al. 57 . Furthermore, other perturbations of the mRNA degradation machinery could be used to directly modulate variability independent of its source.
Finally, where direct manipulation of variability or its underlying generative process is infeasible, its impact can still potentially be assessed by perturbation of downstream effects. For example, transcriptional variability in bone-marrow-derived dendritic cells establishes a paracrine signalling network to create a robust population response to immune challenge 18 . Blocking the paracrine signalling therefore highlights the role of phenotypic variability in immune responses.
Currently, high-throughput omics methods are used to measure and describe correlations with variability, without seeking to resolve causality from consequence 13, 23 . Moving forward, similar experiments using the design principles described above can be used to help establish the contribution of variability to biological processes and to separate cause from consequence.
Interpreting differences in variability. The exact role of variability in biological systems remains controversial. Study of variability in a steady-state system can lead to conflicting conclusions about the role and impact of variability compared with study in the context of fluctuating environments. In particular, this conflict becomes apparent when interpreting the role of variability from an evolutionary perspective. In stable environments, variability in gene expression can be deleterious by leading to suboptimal growth conditions for many cells 64, 138 . Lehner 139 discussed how natural selection minimizes expression variability in genes that show harmful phenotypic effects on overexpression or underexpression ('dosage-sensitive genes'). These genes showed lower expression variability, thus constraining the range of possible expression levels. By contrast, in fluctuating environments where the average protein abundance across cells is far from the level that achieves optimal fitness, increased variability leads to some cells that are capable of expressing protein levels closer to the optimum in the altered environment 105, 140 . This demonstrates the critical importance of studying the role of variability through an evolutionary lens where adaptation to fluctuating environments is key to organismal fitness.
Outlook
The existence of variability in biological systems is undeniable. However, as laid out in this Review, the exact role and impact of variability remain controversial. Specific cases have highlighted that variability may alter the plasticity of cellular behaviour, while others have demonstrated the detrimental effects associated with increased variability. Moving forward, as molecular biology tools become more refined and increase in throughput, they can be applied to resolve some of the controversies in the field.
For instance, high variability is correlated with promoter bivalency. It is still unclear if these conflicting histone modifications occur at the same promoter in the same cell. Single-cell multi-omics can profile the exact promoter state in combination with the transcriptome of individual cells. Furthermore, combining highthroughput, multi-omic and spatially resolved readouts with intelligently designed perturbation experiments will unravel how the multitude of stochastic interactions within cells can result in deterministic behaviour at the population level.
Akin to the benefits of combining human and animal quantitative genetics, there is huge scope for driving forward a deeper understanding of human disease by merging these fields with single-cell omics. In particular, harmonizing human genetics with functional experiments that probe the roles of molecular variability will reap dividends for human health. www.nature.com/nrg
